Yan Li

Case Western Reserve University, Cleveland Heights, OH, United States 
"Yan Li"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Dong C, Simonett SP, Shin S, et al. (2021) INFIMA leverages multi-omics model organism data to identify effector genes of human GWAS variants. Genome Biology. 22: 241
Weng C, Xi J, Li H, et al. (2020) Single-cell lineage analysis reveals extensive multimodal transcriptional control during directed beta-cell differentiation. Nature Metabolism
Karakose E, Wang H, Inabnet W, et al. (2020) Aberrant methylation underlies insulin gene expression in human insulinoma. Nature Communications. 11: 5210
Van Buren E, Hu M, Weng C, et al. (2020) TWO-SIGMA: A novel two-component single cell model-based association method for single-cell RNA-seq data. Genetic Epidemiology
Hsu J, Huang HT, Lee CT, et al. (2020) CHD7 and Runx1 interaction provides a braking mechanism for hematopoietic differentiation. Proceedings of the National Academy of Sciences of the United States of America
Lu L, Liu X, Huang WK, et al. (2020) Robust Hi-C Maps of Enhancer-Promoter Interactions Reveal the Function of Non-coding Genome in Neural Development and Diseases. Molecular Cell
Demir E, Qin T, Li Y, et al. (2020) Cytotoxicity and genotoxicity of cadmium oxide nanoparticles evaluated using in vitro assays. Mutation Research. 850: 503149
Fang Z, Weng C, Li H, et al. (2019) Single-Cell Heterogeneity Analysis and CRISPR Screen Identify Key β-Cell-Specific Disease Genes. Cell Reports. 26: 3132-3144.e7
Elitt MS, Shick HE, Madhavan M, et al. (2018) Chemical Screening Identifies Enhancers of Mutant Oligodendrocyte Survival and Unmasks a Distinct Pathological Phase in Pelizaeus-Merzbacher Disease. Stem Cell Reports
Mack SC, Pajtler KW, Chavez L, et al. (2017) Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling. Nature
See more...